This trial will assess the efficacy of psilocybin-assisted therapy in treating mental healthcare professionals suffering from Major Depressive Disorder, in group and […]
Read more
CALGARY, AB, April 11, 2024 /CNW/ – ATMA Journey Centers Inc. (“ATMA”), a pioneering Canadian company with a primary focus on advancing innovative psychedelic-assisted therapy (PaT) […]
Read more
CALGARY, March 19, 2024 – A revolutionary step in mental health care is now underway through the collaboration between ATMA Journey Centers […]
Read more
CALGARY, March 14, 2024 – ATMA CENA Psychedelic Healthcare Solutions (PHS) is a collaboration of ATMA Journey Centers Inc. (“ATMA”), Cena Life […]
Read more
The initial launch of 10+ network clinics aims to support practitioners in private practice to successfully provide safe and effective psychedelic-assisted therapy […]
Read more
Dr. Aviva will offer invaluable insights derived from her two decades of experience as a medical doctor specializing in addiction treatment, with […]
Read more
CALGARY, October 24, 2023 – ATMA Journey Centers Inc. (“ATMA”), a Canadian company with a primary focus on advancing psychedelic-assisted therapy, is […]
Read more
ATMA and Cena Life Announce Joint-Venture to Support Psychedelic-Assisted Therapy in Canada CALGARY, October 20, 2023 – ATMA Journey Centers Inc. (“ATMA”), […]
Read more
CALGARY, AB, May 4, 2023 /CNW/ – ATMA Journey Centers Inc. (“ATMA”), Canada’s leading psychedelic-assisted therapy training provider, will roll out the first full psychedelic training program in […]
Read more
As psychedelic therapy regulations are being implemented, drafted and discussed globally, the need to educate doctors, psychiatrists and prescribers in psychedelics is greater than ever.
Read more
BACK TO TOP